Skip to main content
Equibles
PHR logo

PHR · Phreesia, Inc. · Metrics

Track PHR — free

Use PHR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PHR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$12.29 -0.32 (-2.54%) At close · Oct 27 Q2 2027 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$782.71M
Shares
62.07M
Volume · Oct 27 646.85K Avg daily vol (3M) 740.66K

PHR metrics

96 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$12.29
Market cap
$782.71M

Price action

20 metrics
Price change (1W)
+11.8%
Price change (30D)
+24.9%
Price change (3M)
+18.6%
Price change (6M)
+31.1%
Price change (YTD)
-25.5%
Price change (1Y)
-46.3%
Trailing year
Price change (5Y)
-81.4%
52-week high
$23.47
52-week low
$8.06
Change from 52-week high
-46.3%
Change from 52-week low
+56.5%
Annualized volatility
58.6%
Annualized volatility (3M)
45.7%
Beta
0.3
RSI (14D)
73.9
Price vs SMA 50
+14.8%
Price vs SMA 200
+14.5%
Avg volume (3M)
743,408
Relative volume
0.8
Average dollar volume
$8.28M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
62.07M

Valuation

12 metrics
P / E (TTM)
70.1
Trailing earnings · reciprocal yield 1.4%
PEG ratio
0.4
EV / revenue
1.5×
reciprocal yield 65.1%
EV / EBITDA
15.7×
reciprocal yield 6.4%
EV / EBIT
62.2×
reciprocal yield 1.6%
P / sales
1.6×
reciprocal yield 64.4%
P / book
2.1
reciprocal yield 47.2%
FCF yield
10.2%
TTM · current market cap
Buyback yield
—
P / FCF
9.8
reciprocal yield 10.2%
P / operating cash flow
8.6
reciprocal yield 11.6%
Earnings yield
1.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
3.1×
reciprocal yield 32.2%
EV / revenue historical average (5Y)
5.6×
reciprocal yield 17.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-09-02

Profitability

9 metrics
Gross margin
—
Operating margin
2.5%
Trailing 12 months
Net margin
2.1%
Gross profit (TTM)
—
Operating profit (TTM)
$12.54M
Net income (TTM)
$10.45M
Trailing 12 months
Diluted EPS (TTM)
$0.18
FCF margin
15.9%
Effective tax rate
-278.0%

Per share

11 metrics
Revenue per diluted share (TTM)
$8.13
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$0.20
EBITDA per diluted share (TTM)
$0.80
Net income per diluted share (TTM)
$0.17
Operating cash flow per diluted share (TTM)
$1.46
Free cash flow per diluted share (TTM)
$1.29
Capital expenditures per diluted share (TTM)
$0.17
R&D per diluted share (TTM)
$1.86
Stock compensation per diluted share (TTM)
$0.95
Book value per share
$5.87

Growth

11 metrics
Revenue growth YoY
+10.4%
Year over year
Net income growth YoY
+193.3%
Revenue (TTM)
$507.79M
Trailing 12 months
EPS growth YoY
+200.0%
Shares change YoY
+1.3%
Year over year · more shares
Revenue CAGR (3Y)
+19.6%
Revenue CAGR (5Y)
+26.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
2.8%
Return on assets
1.6%
Debt / equity
0.2
Current ratio
1.8
EBITDA (TTM)
$49.65M
Free cash flow (TTM)
$80.75M
Quick ratio
1.8
Interest coverage
1.2
Net debt / EBITDA
-0.2
Return on invested capital
—
Trailing 12 months
Net cash
$8.19M
Latest balance sheet
Cash & equivalents
$74.64M
Total assets
$646.98M
Total debt
$66.45M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$91.38M
Capital expenditures (TTM)
$10.63M
R&D (TTM)
$116.28M
SG&A (TTM)
—
Stock compensation (TTM)
$59.43M
R&D / revenue
22.9%
Stock compensation / revenue
11.7%

Ownership (13F)

9 metrics
13F filers
230
13F filer change QoQ
-16
Institutional ownership
94.6%
Conviction holders (share of 13F filers)
0.4%
Crowding (high-turnover and private-fund holders)
27.8%
Private-fund adviser ownership
25.1%
Active holders' share change QoQ
-4.6%
Holder tenure
9.0
Price vs estimated holder cost
-26.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
12.3%

Short interest

3 metrics
Short interest
5.0%
Latest settlement · 5.1 days to cover
Days to cover
5.1d
Short-squeeze score
61 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$67,153
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1412408 CUSIP 71944F106 13F (30d) 35 filings 34 filers Visit website Investor relations